Sintilimab Plus Lenvatinib As Conversion Therapy In Patients With Unresectable Hepatocellular Carcinoma: A Prospective, Non-Randomized, Open-Label, Phase Ii, Expansion Cohort Study
Lenvatinib;Sintilimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Sintilimab Plus Lenvatinib As Conversion Therapy In Patients With Unresectable Hepatocellular Carcinoma: A Prospective, Non-Randomized, Open-Label, Phase Ii, Expansion Cohort Study ### Output: Lenvatinib;Sintilimab